Article added to library!
x
  • UK casinos not on GamStop
    • Pubchase is a service of protocols.io - free, open access, crowdsourced protocols repository. Explore protocols.
    Sign in
    Reset password
    or connect with
    Facebook
    By signing in you are agreeing to our
    Terms Of Service and Privacy Policy
  • See more
    • '); var ntfc_preview = ''; $.post('/api/v1/get_notifications', function(r) { var ntfc_read_pending = 0; var ntfc_pending = 0; $.each(r.notifications.pending, function(index, ntfc_object) { ntfc_read_pending++; ntfc_pending++; if (ntfc_read_pending
    ' + ntfc_object.full_name +'' + ntfc_object.time + '
    ' + ntfc_object.description +'
    '; }) if (ntfc_read_pending
    ' + ntfc_object.full_name +'' + ntfc_object.time + '
    ' + ntfc_object.description +'
    '; }) $('.notification-block .dropdown-menu').html(ntfc_preview); $('.notification-block .dropdown-menu').append('
  • See more
    • '); if (ntfc_pending > 0) { $('.notification-count').text(ntfc_pending).show(); } else { $('.notification-count').hide(); } } else { $('.notification-block .dropdown-menu').html(ntfc_preview); $('.notification-block .dropdown-menu').append('
  • See more
    • '); if (ntfc_pending > 0) { $('.notification-count').text(ntfc_pending).show(); } else { $('.notification-count').hide(); } } if (ntfc_read_pending == 0) { $('.notification-block .dropdown-menu').html('
  • You don\'t have any notifications
  • See more
    • '); $('.notification-count').hide(); } data = {'nid' : '', 'ntid' : 1}; $.post('/api/v1/notification_action', data, function(r) { if (r.request == 'OK') { $('.notification-count').hide(); } }); }, "json"); }); $('.search-save-box').on({ click : function(e) { e.preventDefault(); var search_attr = $(this).attr('rel').split(','); var p = search_attr[1]; var tf = search_attr[0]; window.location = '/search?tf='+tf+'&jc='+jc+'&keywords='+$(this).html()+'&s='+$('#sort_order').val()+'&p='+p; } }, '.search-name'); $( "#keywords_main, #keywords_mobile" ).focus(function(e) { show_saved_searches(e, $(this)); }); $(window).resize(function () { if ($('.search-save-box').is(':visible')) { if ($('#keywords_main').is(':visible')) var left_search_save = $('#keywords_main').offset().left; if ($('#keywords_mobile').is(':visible')) var left_search_save = $('#keywords_mobile').offset().left; $('.search-save-box').css('left',left_search_save); } }); $('.search-save-box').on({ click : function(e) { e.preventDefault(); delete_saved_search($(this)); } }, '.search-name-close'); $('.search-save-box, #keywords_main, #keywords_mobile').click(function(e) { e.stopPropagation(); }); $(document).click(function(e) { $('.search-save-box').hide(); }); $( "#keywords_main, #keywords_mobile" ).autocomplete({ source: function( request, response ) { // data contains the JSON object textStatus contains the status: success, error, etc $.post('/api/v1/searches', {'key' : request.term}, function(data, textStatus) { response(data); }, "json") }, select: function (event, ui) { var reportname = ui.item.value; var thelinks = '/search?tf='+$('#time_frame').val()+'&jc='+jc+'&keywords='+reportname+'&s='+$('#sort_order').val()+'&p='+$('#people_cluster').val(); } }); $('.search-go').click(function(e) { e.preventDefault(); window.location = get_search_url(); }); $('.logout').click(function(e) { e.preventDefault(); }); $('.header_keywords, .home_page_keywords').on('keydown', function(e) { if (e.keyCode == 13) { window.location = get_search_url(); } $('.search-save-box').hide(); }); $('.seemore').click(function(e){ e.stopImmediatePropagation(); }); });
    Add to Library
    [Markers for Predicting Response to Hypomethylating Agents in MDS and AML Patients].
    Dec 28, 2015
    Zhongguo Shi Yan Xue Ye Xue Za Zhi / Zhongguo Bing Li Sheng Li Xue Hui = Journal Of Experimental Hematology / Chinese Association Of Pathophysiology
    Chen XP, Jing Y, Li YH, Yu L
    In many countries the hypomethylating agents (HMAs) are the major compounds to treat patients suffering from myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) with low bone marrow blast counts. The elderly AML patients with poor performance status and comorbidity also benefit from HMAs. Patients who resist to HMA have a poorer outcome as compared to sensitive patients. Therefore, the reliable markers for predicting response to HMAs are urgeatly needed in clinic. In this review, the biomarkers for predicting response of patients with MDS or AML to HMAs are summarized.
      
    Add Public PDF
      
      
    Upload my PDF
      

    Downloading PDF to your library...

    ADD A TAG      64 chars max

      Make private

    APPLIED TAGS

    Uploading PDF...

    PDF uploading

    Delete tag:

    The link you entered does not seem to be valid

    Please make sure the link points to nature.com contains a valid shared_access_token